{
    "Trade/Device Name(s)": [
        "FIDIS VASCULITIS Assay kit",
        "FIDIS Analyzer",
        "CARIS System"
    ],
    "Submitter Information": "Biomedical Diagnostics S.A (bmd)",
    "510(k) Number": "K070458",
    "Predicate Device Reference 510(k) Number(s)": [
        "K053012"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MOB",
        "MVJ"
    ],
    "Summary Letter Date": "December 21, 2007",
    "Summary Letter Received Date": "November 30, 2007",
    "Submission Date": "November 27, 2007",
    "Regulation Number(s)": [
        "21 CFR 866.5660"
    ],
    "Regulation Name(s)": [
        "Multiple autoantibodies immunological test system"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "Myeloperoxidase (MPO)",
        "Serine Proteinase 3 (PR3)",
        "Glomerular Basement Membrane (GBM)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "FIDIS Instrument",
        "MLX-BOOSTER Software",
        "CARIS System"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous fluorescent-based microparticle immunoassay",
        "Flow cytometry"
    ],
    "Methodologies": [
        "Flow cytometry immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Analyzer",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for FIDIS VASCULITIS kit, a multiplex flow cytometry immunoassay for detection of anti-MPO, PR3, and GBM antibodies in human serum.",
    "Indications for Use Summary": "Simultaneous detection of anti-neutrophil cytoplasmic antibodies (MPO, PR3) and anti-glomerular basement membrane antibodies in human serum to aid in the diagnosis of primary systemic small blood vessel vasculitides and glomerular basement membrane disease.",
    "fda_folder": "Immunology"
}